This is the story of two sisters, their love and devotion to one another and how that love continues to grow in helping others.
Linda Seymour was diagnosed with cervical cancer in March of 1988, at 27 years old. Eight months later, at the age of 28, she passed away after extreme suffering from her cancer. Years later her sister, Claire, was diagnosed with a similar cancer and survived. Claire soon discovered from her aunt that their mother had taken DES (Diethylstilbestrol) while pregnant. DES was prescribed to pregnant women in 1940 to 1970 to reduce the risk of pregnancy complications and miscarriages. Subsequent studies have shown and approximate 40-fold increased risk of cervical clear cell adenocarcinoma in women exposed in utero to DES. These women are commonly called "DES daughters." As a DES daughter and the sole survivor of her family, Claire was determined to do whatever she could to help understand the cause, treatment and prevention of all cancers.
The Seymour family embraced music. Linda and her father, John, loved to sing while Claire plays the classical piano. Claire created Prelude to a Cure as a joyful way to raise much needed funding for cancer research while promoting her family's love of music. It is Claire's hope and dream that through the suffering of her family due to cancer, she can make a difference in finding a cure for this disease by bringing together music, medicine and science. Claire soon formed relationships with two women whose lives were impacted by cancer in various ways, to form the Board of Directors. Linda Burger Mead and Meg Mullaney each bring a special talent and unique perspective to the creation and management of Prelude to a Cure.